MX374403B - Secuencia de endolisina kz144 modificada. - Google Patents

Secuencia de endolisina kz144 modificada.

Info

Publication number
MX374403B
MX374403B MX2016006277A MX2016006277A MX374403B MX 374403 B MX374403 B MX 374403B MX 2016006277 A MX2016006277 A MX 2016006277A MX 2016006277 A MX2016006277 A MX 2016006277A MX 374403 B MX374403 B MX 374403B
Authority
MX
Mexico
Prior art keywords
polypeptides
present
nucleic acids
relates
sequence
Prior art date
Application number
MX2016006277A
Other languages
English (en)
Spanish (es)
Other versions
MX2016006277A (es
Inventor
Heike Stüer
Reinhard Sterner
Stefan Miller
Original Assignee
Lysando Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lysando Ag filed Critical Lysando Ag
Publication of MX2016006277A publication Critical patent/MX2016006277A/es
Publication of MX374403B publication Critical patent/MX374403B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2016006277A 2013-11-14 2014-11-14 Secuencia de endolisina kz144 modificada. MX374403B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2013/073869 WO2015070911A1 (en) 2013-11-14 2013-11-14 Modified kz144 endolysin sequence
PCT/EP2014/074671 WO2015071436A1 (en) 2013-11-14 2014-11-14 Modified kz144 endolysin sequence

Publications (2)

Publication Number Publication Date
MX2016006277A MX2016006277A (es) 2017-01-05
MX374403B true MX374403B (es) 2025-03-06

Family

ID=49582760

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006277A MX374403B (es) 2013-11-14 2014-11-14 Secuencia de endolisina kz144 modificada.

Country Status (10)

Country Link
US (1) US10184120B2 (cg-RX-API-DMAC7.html)
JP (1) JP6745720B2 (cg-RX-API-DMAC7.html)
KR (1) KR102302044B1 (cg-RX-API-DMAC7.html)
CN (1) CN105793419B (cg-RX-API-DMAC7.html)
AU (1) AU2014350104B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016011091B1 (cg-RX-API-DMAC7.html)
CA (1) CA2929686C (cg-RX-API-DMAC7.html)
EA (1) EA035959B1 (cg-RX-API-DMAC7.html)
MX (1) MX374403B (cg-RX-API-DMAC7.html)
WO (2) WO2015070911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2934714T3 (es) 2015-09-17 2023-02-24 Contrafect Corp Polipéptidos de lisina activos contra bacterias Gram-negativas
AU2017255962B2 (en) * 2016-04-28 2023-02-23 Lysando Ag Antimicrobial agents against Salmonella bacteria
EP3464583A1 (en) 2016-05-27 2019-04-10 Sasinapas Co., Ltd. Endolysin variant
WO2018100408A1 (en) * 2016-11-30 2018-06-07 Sasinapas Co.,Ltd. Modified peptides
KR20240162610A (ko) * 2017-04-03 2024-11-15 사시나파스 컴퍼니 리미티드 조작된 그람-음성 엔도리신
US20210198645A1 (en) * 2018-05-30 2021-07-01 Lysando Ag Novel antimicrobial fusion proteins
CN111304181B (zh) * 2020-02-17 2021-11-23 华东理工大学 一种基因工程改造后的副溶血性弧菌噬菌体裂解酶及其制备方法和应用
KR20250044545A (ko) 2023-09-23 2025-04-01 조배근 사료급이기 청소기

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289092C (en) * 1987-01-15 1991-09-17 Novartis Vaccines And Diagnostics, Inc. Thermostable human cu/zn superoxide dismutase muteins
EP0285123A3 (en) 1987-04-03 1989-02-01 Stabra AG A method for complete mutagenesis of nucleic acids
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
JPH08127540A (ja) * 1994-09-09 1996-05-21 Takeda Chem Ind Ltd 抗潰瘍医薬
CN101952424A (zh) * 2007-08-22 2011-01-19 海格罗斯投资有限责任公司 用于人类和动物葡萄球菌感染的新蛋白
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
US20120195872A1 (en) 2009-06-26 2012-08-02 Lysando Ag Antimicrobial agents
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
JP5847081B2 (ja) * 2009-08-24 2016-01-20 カトリック ユニバーシテイト ルーベン ケイ.ユー. ルーベン アール アンド ディー エンドリシンOBPgpLYS
DK2563916T3 (en) * 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
GB201018518D0 (en) * 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (en) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
KR20130142837A (ko) * 2012-06-20 2013-12-30 한국외국어대학교 연구산학협력단 슈도모나스 에루기노사의 박테리오파아지 및 그 용도

Also Published As

Publication number Publication date
BR112016011091B1 (pt) 2024-02-06
AU2014350104A1 (en) 2016-05-12
AU2014350104B2 (en) 2020-03-05
MX2016006277A (es) 2017-01-05
NZ719338A (en) 2022-03-25
US20160281074A1 (en) 2016-09-29
WO2015071436A1 (en) 2015-05-21
CA2929686A1 (en) 2015-05-21
KR102302044B1 (ko) 2021-09-15
JP2016537979A (ja) 2016-12-08
CA2929686C (en) 2023-08-08
KR20160085342A (ko) 2016-07-15
EA201691004A1 (ru) 2017-01-30
CN105793419A (zh) 2016-07-20
JP6745720B2 (ja) 2020-08-26
US10184120B2 (en) 2019-01-22
WO2015070911A1 (en) 2015-05-21
EA035959B1 (ru) 2020-09-07
CN105793419B (zh) 2021-06-01
BR112016011091A2 (pt) 2017-12-05

Similar Documents

Publication Publication Date Title
EA201691004A1 (ru) Последовательность модифицированного эндолизина kz144
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
MX2020005458A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
MX385926B (es) Proteínas de fusión de citoquinas.
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
BR112017015567A2 (pt) proteína gl de citomegalovírus recombinante ou fragmento de formação de complexo da mesma, complexo de citomegalovírus, ácido nucleico isolado, célula hospedeira, e, composição imunogênica
WO2014202616A3 (en) Rasamsonia gene and use thereof
MX392247B (es) Composiciones detergentes.
PH12013502234A1 (en) Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
EA201401211A1 (ru) Улучшенные варианты фермента химозина
EP4223772A3 (en) Optimized factor viii gene
EA201890914A1 (ru) Доставка белка бактериями
WO2014202622A3 (en) Rasamsonia gene and use thereof
BR112017020308A2 (pt) udp-glicosiltransferases
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
EP3760713A3 (en) Lipase variants and polynucleotides encoding same
MX382218B (es) Variantes de lipasa y polinucleotidos que las codifican.
MX2011004483A (es) Leucolectinas y sus usos.
NZ706884A (en) Fc gamma receptor iib variants
EA201590431A1 (ru) Пшеница с новыми аллелями rht-b1
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
EA201691981A1 (ru) Улучшенные транспортные молекулы модулярного антигена и их применение
AR101146A1 (es) Proteína con actividad xilanasa

Legal Events

Date Code Title Description
FG Grant or registration